Latest filing published 06 Jan 2025 for BICYCLE THERAPEUTICS plc.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Santiago Arroyo: trading record in brief
Santiago Arroyo (board member) discloses dealings in 3 companies, chiefly Momenta Pharmaceuticals Inc, BICYCLE THERAPEUTICS plc and Marinus Pharmaceuticals, Inc. In total, 47 filings cover trades dated from 20 June 2017 to 2 January 2025.
No open-market purchase appears, only 23 sales worth €6.9M. Besides market trades, the filings include 12 share grants and 10 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
Most recently, on 6 January 2025, the filings show an open-market sale worth €67k in BICYCLE THERAPEUTICS plc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Santiago Arroyo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Ordinary SharesSEC:0001415889-25-000926:0
- 21,660 shares0Ordinary SharesSEC:0001415889-24-003009:0
- 17,340 shares0Ordinary SharesSEC:0001209191-24-000880:0
- 2,750 shares0Common StockSEC:0001104659-22-012777:0
4 of 4 declarations
